A clinical trial of MK-6916 in healthy participants (MK-6916-010)
Pain affects millions of people across the UK, whether from sudden injuries or long-term conditions like arthritis. Researchers are currently developing an experimental medicine called MK-6916 to help treat both short-term (acute) and long-term (chronic) pain. Before a new pain medicine can be tested in patients who are unwell, doctors must first see how it behaves in healthy bodies. This study is an early-stage Phase 1 trial. Its main goal is to check how safe MK-6916 is, how the human body absorbs and breaks it down, and whether it causes any unwanted side effects. The trial is open to healthy adults aged 18 and over, both men and women. Taking part will involve health checks, taking the study drug under close medical supervision, and attending follow-up appointments. Volunteers receive close medical monitoring throughout the trial.
At a glance
What is this study about?
Pain is one of the most common reasons people seek medical help in the UK. Short-term pain can happen after an injury or surgery, while long-term pain can last for months or years. Although there are pain relief medicines available today, many have difficult side effects or do not work well enough for everyone. Because of this, scientists are constantly searching for new, safer ways to relieve pain.
This study focuses on an investigational medicine known as MK-6916. An investigational medicine is a treatment that is still being tested in clinical research and is not yet approved for general use. The researchers hope that MK-6916 may one day become a useful option for people living with acute or chronic pain.
Before testing whether the medicine relieves pain in patients, doctors need to understand its basic safety in humans. In this Phase 1 trial, doctors will give MK-6916 to healthy adult volunteers. They will carefully track how the medicine enters the bloodstream, how long it stays in the body, and how well people tolerate it. The findings will help doctors decide if and how to proceed to larger studies in people experiencing pain.
Key takeaways
- This is an early-stage Phase 1 trial testing a new pain medicine called MK-6916.
- The study is open to healthy adults aged 18 and older, both men and women.
- The main aim is to check the medicine's safety and how the human body processes it.
- Healthy volunteers do not get direct health benefits, but help advance medical research.
- Participation is entirely voluntary, and you can withdraw at any time.
Who may be eligible?
This trial is looking for healthy adult volunteers. You must be at least 18 years old to take part. Both men and women are welcome to apply.
Because this is a Phase 1 safety trial, you should be in good general health without any major medical conditions. Even though the medicine is being developed for pain, participants in this specific study should not have active chronic pain conditions or require daily pain relief.
The trial team will check your overall health before you can join. This usually includes a physical examination, blood tests, heart checks, and a review of your medical history to ensure it is safe for you to take part.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am aged 18 or older.
- I consider myself to be in good general health.
- I do not have a serious ongoing medical illness or chronic pain condition.
- I am willing to undergo blood tests, heart checks, and health screenings.
- I am able to attend clinic appointments and follow the study team's instructions.
What does participation involve?
If you decide to join this trial, you will first attend a screening visit to make sure the study is a safe fit for you. During the study, you will take the study drug under the supervision of medical staff. You will need to attend regular clinic visits, and some Phase 1 studies may require a short stay at the research clinic so doctors can monitor you closely.
Throughout the study, doctors and nurses will check your heart rate, blood pressure, and take blood and urine samples to see how the medicine moves through your body. You will also be asked to report any unusual feelings or side effects. After receiving the study medicine, you will attend follow-up visits so the team can confirm that you remain well. The study team will provide full details on the exact visit schedule and total duration before you agree to join.
Potential risks and benefits
Locations (1)
- —UnverifiedBelgium
Common questions
Do I need to have pain to join this trial?
No. This early trial is looking for healthy volunteers without pain to test how the body safely handles the medicine.
What is a Phase 1 clinical trial?
A Phase 1 trial is one of the earliest stages of human testing. It focuses mainly on safety, side effects, and how a medicine is absorbed, rather than how well it treats an illness.
Will taking part cost me anything?
Clinical trials generally provide the study medicine and tests at no cost. Early-stage trials often provide compensation for your time and travel expenses.
Can I leave the study if I change my mind?
Yes. You have the right to withdraw from the study at any time, for any reason, without giving an explanation.
How is my safety protected during the study?
You will be looked after by qualified doctors and nurses who will check your health regularly with blood tests and physical exams.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.